ICG, the global alternative asset manager announced that its Asia Pacific Corporate team (“ICG APAC Corporate”) has closed its investment in day surgery operator, Alfa Medicus Pte. Ltd. (“Alfa Medicus” or the “Company”), alongside the Company’s founder, Dr Lim Beng Hai, and a consortium of healthcare professionals, including doctor-shareholders and management. Financial details of the transaction have not been disclosed.
Read also – SCBX Acquires Home Credit Vietnam business From Home Credit Group
Alfa Medicus established the first day surgery centre in Singapore in 2008, following growing demand among patients for quality day surgery facilities able to deliver best-in-class yet cost-effective outcomes. Alfa Medicus has grown to become a leading private day surgery operator in Singapore, complete with a synergistic platform of day surgery centres, diagnostic imaging and specialist clinics.
Read also – Silence Laboratories Secures $4.1 Mn Pre-Series A Funding
Escamillo Lin, Managing Director and Head of Southeast Asia at ICG, commented: Alfa Medicus is a market-leading private day hospital platform, benefitting from an A-team management strong on execution and an organisational culture prioritising surgeon satisfaction and patient care. We are delighted to partner with Dr Lim as the business continues to expand into strategic adjacencies.
Wooseok Jun, Head of ICG Asia Pacific Corporate, said:This partnership builds on ICG’s extensive track record within the Asia-Pacific healthcare sector, and underpins our approach to supporting high-quality businesses committed to delivering meaningful contributions to the markets within which we operate.
About ICG
ICG provides flexible capital solutions to help companies develop and grow. We are a leading global alternative asset manager with over 30 years’ history, managing $86.3bn of assets* and investing across the capital structure. We operate across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credi
